OtherTheranostics
Open Access
Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
Kim M. Pabst, Marija Trajkovic-Arsic, Phyllis F.Y. Cheung, Simone Ballke, Katja Steiger, Timo Bartel, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Robert Seifert, Michael Nader, Lukas Kessler, Jens T. Siveke, Katharina Lueckerath, Stefan Kasper, Ken Herrmann, Nader Hirmas, Hartmut H. Schmidt, Rainer Hamacher and Wolfgang P. Fendler
Journal of Nuclear Medicine April 2023, jnumed.122.265215; DOI: https://doi.org/10.2967/jnumed.122.265215
Kim M. Pabst
1 Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Germany;
Marija Trajkovic-Arsic
2 German Cancer Consortium, partner site University Hospital Essen, Germany;
Phyllis F.Y. Cheung
2 German Cancer Consortium, partner site University Hospital Essen, Germany;
Simone Ballke
3 Institute of Pathology, School of Medicine, Technical University of Munich, Germany;
Katja Steiger
3 Institute of Pathology, School of Medicine, Technical University of Munich, Germany;
Timo Bartel
1 Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Germany;
Benedikt M. Schaarschmidt
4 Diagnostic and Interventional Radiology, University Hospital Essen, University of Duisburg-Essen, Germany;
Aleksandar Milosevic
4 Diagnostic and Interventional Radiology, University Hospital Essen, University of Duisburg-Essen, Germany;
Robert Seifert
1 Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Germany;
Michael Nader
1 Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Germany;
Lukas Kessler
1 Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Germany;
Jens T. Siveke
2 German Cancer Consortium, partner site University Hospital Essen, Germany;
Katharina Lueckerath
1 Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Germany;
Stefan Kasper
2 German Cancer Consortium, partner site University Hospital Essen, Germany;
Ken Herrmann
1 Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Germany;
Nader Hirmas
1 Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Germany;
Hartmut H. Schmidt
5 Medical Clinic B, University Hospital Münster, Germany
Rainer Hamacher
2 German Cancer Consortium, partner site University Hospital Essen, Germany;
Wolfgang P. Fendler
1 Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Germany;

Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
Kim M. Pabst, Marija Trajkovic-Arsic, Phyllis F.Y. Cheung, Simone Ballke, Katja Steiger, Timo Bartel, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Robert Seifert, Michael Nader, Lukas Kessler, Jens T. Siveke, Katharina Lueckerath, Stefan Kasper, Ken Herrmann, Nader Hirmas, Hartmut H. Schmidt, Rainer Hamacher, Wolfgang P. Fendler
Journal of Nuclear Medicine Apr 2023, jnumed.122.265215; DOI: 10.2967/jnumed.122.265215
Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
Kim M. Pabst, Marija Trajkovic-Arsic, Phyllis F.Y. Cheung, Simone Ballke, Katja Steiger, Timo Bartel, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Robert Seifert, Michael Nader, Lukas Kessler, Jens T. Siveke, Katharina Lueckerath, Stefan Kasper, Ken Herrmann, Nader Hirmas, Hartmut H. Schmidt, Rainer Hamacher, Wolfgang P. Fendler
Journal of Nuclear Medicine Apr 2023, jnumed.122.265215; DOI: 10.2967/jnumed.122.265215
Jump to section
Related Articles
Cited By...
- Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
- Prognostic Implications of 68Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors
- 68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-FAPI PET Observational Trial